Evidence map›Paper›PMID 7650487›Full record

ArticleThe Journal of experimental medicine1995

Involvement of p59fynT in interleukin-5 receptor signaling.

M W Appleby, J D Kerner, S Chien, C R Maliszewski, S Bondada, R M Perlmutter, S ] Bondadaa S [corrected to Bondada

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in The Journal of experimental medicine, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Malignant transformation of early lymphoid progenitors in mice expressing an activated Blk tyrosine kinase.Proceedings of the National Academy of Sciences of the United States of America · 1998
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

M W ApplebyHoward Hughes Medical Institute, Seattle, Washington 98195, USA.
J D Kerner
S Chien
C R Maliszewski
S Bondada
R M Perlmutter
S ] Bondadaa S [corrected to Bondada
Howard Hughes Medical Institute · US

Funding

LYMPHOCYTE-SPECIFIC PROTEIN TYROSINE KINASE GENESR01CA045682 · NCI · UNIVERSITY OF WASHINGTON · PI PERLMUTTER, ROGER M · 1987 to 1996
–
NCI NIH HHS CA45682
6 · The paper itself

Abstract

Previous studies implicate the nonreceptor protein tyrosine kinase (PTK) p59fyn in the propagation of signals from the B cell antigen receptor. To elucidate the functions of this kinase, we examined B cell responsiveness in mice engineered to lack the hematopoietic isoform of p59fyn. Remarkably, antigen receptor signaling was only modestly defective in fynTnull B cells. In contrast, signaling from the interleukin (IL)-5 receptor which ordinarily provides a comitogenic stimulus with antiimmunoglobulin, was completely blocked. Our results document the importance of p59fynT in IL-5 responses in B cells, and they support a general model for cytokine receptor signal transduction involving the simultaneous recruitment of at least three families of PTK.

Indexed as

AnimalsAntigensAntigens, T-IndependentB-LymphocytesFemaleImmunizationInterleukin-5MaleMiceMice, KnockoutPhosphorylationProtein Processing, Post-TranslationalProto-Oncogene ProteinsProto-Oncogene Proteins c-fynReceptors, Antigen, B-CellReceptors, InterleukinAntigensAntigens, T-IndependentFyn protein, mouseInterleukin-5Proto-Oncogene ProteinsProto-Oncogene Proteins c-fynReceptors, Antigen, B-CellReceptors, InterleukinReceptors, Interleukin-5

Identifiers

PMID7650487
PMCPMC2192161
OpenAlexW2137517579

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.